Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

2.04%

24.0¢ paradigm biopharmaceuticals limited..

Ann: Response to ASX Query, page-22

First 22 Last

Share
Profile

Follow
Absentfriend

570 Posts.

42

22/01/21

19:55

Post #: 50388086
Share

Originally posted by Willem007: ↑

I am no expert, but I'd assume the pharma industry is as cut throat as any other industry where this money is involved.
So, having listened to the presentation at the 39th JP Morgan whatever and reading the report, I would think that some big pharma was listening and that the very next thing said big pharma would do is to check if Paradigm has a chink in their armor.
Check the phase 2 results to see if they think this might work or not.
Check patents.
Check supply agreements.
Check with their buddies in the FDA if a few palms can be greased (joking, I am sure all of this is completely above board).
Etc.
Why pay premium for a company if you can run the trials in half the time for a fraction of the cost of a takeover should there indeed be a chink in Paradigm's armor.
Hopefully they then find everything stitched up neatly, after which they will start to purchase shares to a point where they have to declare it (no idea how that works) after which they will want to talk shop.
And I think this is all about to go down in the next two weeks or so.

I really hope Yamaha brings out a fishing jetski this year: cause I am ordering one right now!

Expand

Just make sure you don’t buy a yellow one...you guessed it...

... it might exPARlode

PAR Price at posting: $2.38 Sentiment: Buy Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

RKT

RocketDNA wins $350K contract to supply mine sits with autonomous security 'PatrolBots'

EMD

Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA

ARL

Ardea inks JV deal with Japanese consortium to progress its Kalgoorlie Nickel Project

BGL

Bellevue Gold inks maiden $75M profit for FY24 after gold production kicked off in May

IMU

Imugene's azer-cel trial sees tumours temporarily disappear in 3 of 10 patients

There are more pages in this discussion • 6 more messages in this thread...

First 22 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 24.0¢		Change -0.005(2.04%)		Mkt cap ! $85.70M

Open	High	Low	Value	Volume
24.5¢	24.5¢	24.0¢	$2.504K	10.22K

Buyers (Bids)

No.	Vol.	Price($)
4	65340	24.0¢

Sellers (Offers)

Price($)	Vol.	No.
24.5¢	37222	4

View Market Depth

No.	Vol.	Price($)
4	65340	0.240
7	114610	0.235
10	158150	0.230
11	212234	0.225
15	181137	0.220

Price($)	Vol.	No.
0.245	35422	3
0.250	4057	2
0.255	81349	8
0.260	108149	4
0.265	1800	1

Last trade - 10.48am 02/09/2024 (20 minute delay)

PAR (ASX) Chart

SPONSORED BY